Manual Diaphragmatic Release: Is It Helpful for Cleaning-laborers With Work-related Respiratory Hazards in Overcoming the Upsetting Respiratory Symptoms, Boosting Immune Response, and Enhancing Functional Ability?
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Respiratory System Abnormalities
- Sponsor
- Maged Basha
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- Forced vital capacity
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This study intended to examine the effect of manual diaphragm release on pulmonary function, chest wall mobility, and functional ability in female occupational cleaners with respiratory hazards.
Detailed Description
Cleaning chores have been linked to exposure to various chemical agents that have the potential to cause harmful effects on both the respiratory system and cardiovascular markers, many cleaning products and disinfectants contain ingredients that can act as airway irritants. One of the physical therapy procedures that is used to manage chest disorders is manual diaphragm release which aims to lengthen the diaphragm musculature whereas encouraging better and more proficient contraction.
Investigators
Maged Basha
Assistant Professor, College of Medical Rehabilitation, Qassim University
Qassim University
Eligibility Criteria
Inclusion Criteria
- •Female occupational cleaners.
- •Age between 35 and
- •Had work-related respiratory hazards.
- •Clinically stable.
- •No exacerbation in the previous 6 weeks.
- •Working in an occupation with respiratory hazards for at least 2 years.
- •Mild to moderate air way obstruction.
- •Willingness to participate in this study and provide a consent form.
Exclusion Criteria
- •Other cardiopulmonary diseases.
- •Body mass index \> 30 kg/ m
- •Previous thoracic or abdominal surgery.
- •Smokers and users of tobacco in any form (chewing, snuffing or water pipe).
- •Systemic conditions (e.g., diabetes mellitus, hypertension).
- •Sever airway obstructions.
- •Inability to perform the required exercises.
- •Inability to attend the scheduled sessions.
Outcomes
Primary Outcomes
Forced vital capacity
Time Frame: after 12 weeks
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Serum IgE
Time Frame: after 12 weeks
The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm.
Forced expiratory volume in one second
Time Frame: after 12 weeks
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
pulmonary expiratory flow
Time Frame: after 12 weeks
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Secondary Outcomes
- Functional performance(after 12 weeks)
- Chest wall mobility(after 12 weeks)